4 reports

  • RENAL PHARMA LTD
  • ASTRAZENECA

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest...

  • Pharmaceutical
  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Innate Pharma
  • Innate Pharma SA, Pharmaceuticals & Healthcare, Deal Details
  • Innate Pharma SA, Subsidiaries

Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products.The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies...

  • Healthcare
  • Pharmaceutical
  • United States
  • Innate Pharma
  • COMPANY- INNATE PHARMA S.A.
  • COMPANY- INNATE PHARMA

“IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS” gives comprehensive insights on the various Immune Checkpoint modulators being developed for the treatment of various diseases. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines...

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Agenus Inc.
  • Innate Pharma
  • INNATE PHARMA: IMMUNE CHECKPOINT INHIBITORS PIPELINE, 2015
  • INNATE PHARMA: IMMUNE CHECKPOINT INHIBITORS PARTNERSHIPS

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug...

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • Market Size
  • Innate Pharma